Literature DB >> 6750768

Cell cycle distribution of erythroblasts in P. falciparum malaria.

S N Wickramasinghe, S Abdalla, D J Weatherall.   

Abstract

The cell cycle distribution of the erythroblasts of 6 Gambian children with P. falciparum malaria was determined using the technique of combined Feulgen microspectrophotometry and 3H-thymidine autoradiography. The data showed evidence of a perturbation of erythroblast kinetics in all 6 children. The abnormalities were more marked in the children with chronic malaria than in those with acute malaria and predominantly affected the early polychromatic erythroblasts. The disturbances observed in chronic malaria included an increased proportion of cells in the G2 phase and an arrest during the progress of some cells through the S phase. The latter defect was not seen in the children with acute malaria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6750768     DOI: 10.1111/j.1600-0609.1982.tb00567.x

Source DB:  PubMed          Journal:  Scand J Haematol        ISSN: 0036-553X


  4 in total

1.  Tumor necrosis factor alpha and the anemia associated with murine malaria.

Authors:  K L Miller; P H Silverman; B Kullgren; L J Mahlmann
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

2.  Ineffective erythropoiesis in acute human P. falciparum malaria.

Authors:  P Dörmer; M Dietrich; P Kern; R D Horstmann
Journal:  Blut       Date:  1983-05

3.  Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection.

Authors:  K Mohan; H Sam; M M Stevenson
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  A primate model of severe malarial anaemia: a comparative pathogenesis study.

Authors:  Amber I Raja; Elizabeth B Brickley; Jessica Taaffe; Timmy Ton; Zhen Zhao; Kevin W Bock; Sachy Orr-Gonzalez; Marvin L Thomas; Lynn E Lambert; Ian N Moore; Patrick E Duffy
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.